Medicine Access Programmes: what do patients think – a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia

IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL Internal Medicine Journal Pub Date : 2024-10-28 DOI:10.1111/imj.16536
Natasha Yap, Vanessa Wong, Catherine Morton, Richard de Boer, Sally Baron-Hay, Robert Blum, Benjamin Forster, Susan Chua, Kerrie Clarke, Katharine Cuff, Michael Green, Elgene Lim, Kelly Mok, Louise Nott, Michelle Nottage, Ali Tafreshi, Daphne Tsoi, Anthony Uccellini, Peter Gibbs, Sheau Wen Lok
{"title":"Medicine Access Programmes: what do patients think – a patient-reported outcome study on ribociclib in metastatic breast cancer in Australia","authors":"Natasha Yap,&nbsp;Vanessa Wong,&nbsp;Catherine Morton,&nbsp;Richard de Boer,&nbsp;Sally Baron-Hay,&nbsp;Robert Blum,&nbsp;Benjamin Forster,&nbsp;Susan Chua,&nbsp;Kerrie Clarke,&nbsp;Katharine Cuff,&nbsp;Michael Green,&nbsp;Elgene Lim,&nbsp;Kelly Mok,&nbsp;Louise Nott,&nbsp;Michelle Nottage,&nbsp;Ali Tafreshi,&nbsp;Daphne Tsoi,&nbsp;Anthony Uccellini,&nbsp;Peter Gibbs,&nbsp;Sheau Wen Lok","doi":"10.1111/imj.16536","DOIUrl":null,"url":null,"abstract":"<p>This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development.</p>","PeriodicalId":13625,"journal":{"name":"Internal Medicine Journal","volume":"54 11","pages":"1894-1897"},"PeriodicalIF":1.8000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Internal Medicine Journal","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/imj.16536","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

This study evaluated patient-reported outcomes (PROs) of Medicine Access Programmes (MAPs) for Australian metastatic breast cancer patients on ribociclib. Limited patient awareness of MAP enrolment was identified, emphasising the need for improved education and consent processes. Most patients expressed gratitude for accessing non-funded medications and perceived enhanced medication adherence as a key benefit. Integrating PRO data with real-world registry data provides comprehensive insight for future MAP development.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
药物获取计划:患者怎么看--澳大利亚转移性乳腺癌患者对利博昔布治疗效果的报告研究。
本研究评估了澳大利亚转移性乳腺癌患者服用瑞博西来(ribociclib)后的药物获取计划(MAP)的患者报告结果(PROs)。研究发现,患者对加入 MAP 的认识有限,这强调了改进教育和同意程序的必要性。大多数患者对获得非资助药物表示感谢,并认为提高服药依从性是一项主要益处。将PRO数据与真实世界登记数据相结合,可为未来的MAP开发提供全面的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Internal Medicine Journal
Internal Medicine Journal 医学-医学:内科
CiteScore
3.50
自引率
4.80%
发文量
600
审稿时长
3-6 weeks
期刊介绍: The Internal Medicine Journal is the official journal of the Adult Medicine Division of The Royal Australasian College of Physicians (RACP). Its purpose is to publish high-quality internationally competitive peer-reviewed original medical research, both laboratory and clinical, relating to the study and research of human disease. Papers will be considered from all areas of medical practice and science. The Journal also has a major role in continuing medical education and publishes review articles relevant to physician education.
期刊最新文献
Final results of the National Oncology Mentorship Program 2023 and its impact on burnout and professional fulfilment. Platelet factor 4 immune disease: medical emergencies that look like heparin-induced thrombocytopenia. Correction to: 'Managing cancer-related pain in the setting of proven IgE-mediated opioid anaphylaxis'. Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer. Environmental impact of large language models in medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1